你好_世界_2025:刚刚 Novavax 在官网发布了上季度的财报信息:
Achieved total revenue for the third quarter of $735 million
Delivered over 94 million doses of NVX-CoV2373 globally to date
Authorized as a booster for adults in the U.S., E.U., and additional markets
Authorized as a primary series for